Autopsy report · NCT00869518

Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults

“Poor enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 1 year 5 months before it stopped.
• 12 participants enrolled.
• Results were posted on the registry 3 years 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of California, San Francisco

Sponsor type

University, hospital or other

Conditions

Staphylococcus Aureus; HIV Infections

Interventions

rifabutin plus trimethoprim sulfamethoxazole; placebo plus trimethoprim-sulfamethoxazole

Participants

12

Sites

1

Countries

United States

Trials that died the same way

• Use of Prokinetics in Early Enteral Feeding in Preterm Infants
  “very poor enrollment” (96% match in meaning)
• Embozene Microspheres for Uterine Fibroid Embolization (UFE)
  “Inadequate enrollment” (91% match in meaning)
• Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic Subjects
  “Low enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.